NASDAQ:AVCO

Avalon GloboCare Competitors

$0.99
+0.01 (+1.02 %)
(As of 04/20/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.96
Now: $0.99
$1.00
50-Day Range
$0.95
MA: $1.14
$1.29
52-Week Range
$0.90
Now: $0.99
$2.19
Volume228,554 shs
Average Volume421,573 shs
Market Capitalization$83.30 million
P/E RatioN/A
Dividend YieldN/A
Beta0.57

Competitors

Avalon GloboCare (NASDAQ:AVCO) Vs. GIB, BAH, G, EXPO, FCN, and ICFI

Should you be buying AVCO stock or one of its competitors? Companies in the industry of "management consulting services" are considered alternatives and competitors to Avalon GloboCare, including CGI (GIB), Booz Allen Hamilton (BAH), Genpact (G), Exponent (EXPO), FTI Consulting (FCN), and ICF International (ICFI).

CGI (NYSE:GIB) and Avalon GloboCare (NASDAQ:AVCO) are both computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, institutional ownership, profitability, analyst recommendations and valuation.

Earnings and Valuation

This table compares CGI and Avalon GloboCare's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CGI$9.04 billion2.39$831.69 million$3.6323.46
Avalon GloboCare$1.55 million53.74$-18,070,000.00N/AN/A

CGI has higher revenue and earnings than Avalon GloboCare.

Analyst Ratings

This is a summary of current ratings and price targets for CGI and Avalon GloboCare, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CGI04902.69
Avalon GloboCare0000N/A

CGI presently has a consensus target price of $107.95, suggesting a potential upside of 26.78%. Given CGI's higher possible upside, analysts plainly believe CGI is more favorable than Avalon GloboCare.

Institutional and Insider Ownership

51.3% of CGI shares are held by institutional investors. Comparatively, 3.2% of Avalon GloboCare shares are held by institutional investors. 9.9% of CGI shares are held by company insiders. Comparatively, 73.4% of Avalon GloboCare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Volatility and Risk

CGI has a beta of 1.03, indicating that its share price is 3% more volatile than the S&P 500. Comparatively, Avalon GloboCare has a beta of 0.57, indicating that its share price is 43% less volatile than the S&P 500.

Profitability

This table compares CGI and Avalon GloboCare's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CGI9.20%18.58%8.79%
Avalon GloboCare-1,071.90%-314.81%-134.45%

Summary

CGI beats Avalon GloboCare on 9 of the 11 factors compared between the two stocks.

Booz Allen Hamilton (NYSE:BAH) and Avalon GloboCare (NASDAQ:AVCO) are both business services companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, analyst recommendations, profitability, risk and earnings.

Analyst Ratings

This is a summary of recent ratings and target prices for Booz Allen Hamilton and Avalon GloboCare, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Booz Allen Hamilton04602.60
Avalon GloboCare0000N/A

Booz Allen Hamilton presently has a consensus target price of $85.2857, suggesting a potential upside of 2.27%. Given Booz Allen Hamilton's higher possible upside, research analysts clearly believe Booz Allen Hamilton is more favorable than Avalon GloboCare.

Profitability

This table compares Booz Allen Hamilton and Avalon GloboCare's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Booz Allen Hamilton6.62%54.01%10.09%
Avalon GloboCare-1,071.90%-314.81%-134.45%

Institutional & Insider Ownership

89.9% of Booz Allen Hamilton shares are owned by institutional investors. Comparatively, 3.2% of Avalon GloboCare shares are owned by institutional investors. 2.0% of Booz Allen Hamilton shares are owned by insiders. Comparatively, 73.4% of Avalon GloboCare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares Booz Allen Hamilton and Avalon GloboCare's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Booz Allen Hamilton$7.46 billion1.54$482.60 million$3.1826.22
Avalon GloboCare$1.55 million53.74$-18,070,000.00N/AN/A

Booz Allen Hamilton has higher revenue and earnings than Avalon GloboCare.

Risk & Volatility

Booz Allen Hamilton has a beta of 0.81, suggesting that its share price is 19% less volatile than the S&P 500. Comparatively, Avalon GloboCare has a beta of 0.57, suggesting that its share price is 43% less volatile than the S&P 500.

Summary

Booz Allen Hamilton beats Avalon GloboCare on 9 of the 11 factors compared between the two stocks.

Avalon GloboCare (NASDAQ:AVCO) and Genpact (NYSE:G) are both business services companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, valuation, analyst recommendations and institutional ownership.

Risk & Volatility

Avalon GloboCare has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500. Comparatively, Genpact has a beta of 1.32, indicating that its stock price is 32% more volatile than the S&P 500.

Valuation & Earnings

This table compares Avalon GloboCare and Genpact's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avalon GloboCare$1.55 million53.74$-18,070,000.00N/AN/A
Genpact$3.52 billion2.38$304.88 million$1.5628.67

Genpact has higher revenue and earnings than Avalon GloboCare.

Profitability

This table compares Avalon GloboCare and Genpact's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Avalon GloboCare-1,071.90%-314.81%-134.45%
Genpact8.53%21.81%7.90%

Insider and Institutional Ownership

3.2% of Avalon GloboCare shares are owned by institutional investors. Comparatively, 97.5% of Genpact shares are owned by institutional investors. 73.4% of Avalon GloboCare shares are owned by company insiders. Comparatively, 1.9% of Genpact shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Avalon GloboCare and Genpact, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Avalon GloboCare0000N/A
Genpact02502.71

Genpact has a consensus target price of $43.00, indicating a potential downside of 3.85%. Given Genpact's higher probable upside, analysts clearly believe Genpact is more favorable than Avalon GloboCare.

Summary

Genpact beats Avalon GloboCare on 9 of the 11 factors compared between the two stocks.

Avalon GloboCare (NASDAQ:AVCO) and Exponent (NASDAQ:EXPO) are both business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, profitability, institutional ownership, risk and valuation.

Volatility and Risk

Avalon GloboCare has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500. Comparatively, Exponent has a beta of 0.32, indicating that its stock price is 68% less volatile than the S&P 500.

Valuation & Earnings

This table compares Avalon GloboCare and Exponent's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avalon GloboCare$1.55 million53.74$-18,070,000.00N/AN/A
Exponent$417.20 million12.09$82.46 million$1.5363.61

Exponent has higher revenue and earnings than Avalon GloboCare.

Profitability

This table compares Avalon GloboCare and Exponent's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Avalon GloboCare-1,071.90%-314.81%-134.45%
Exponent19.63%23.66%15.24%

Insider and Institutional Ownership

3.2% of Avalon GloboCare shares are owned by institutional investors. Comparatively, 90.3% of Exponent shares are owned by institutional investors. 73.4% of Avalon GloboCare shares are owned by insiders. Comparatively, 2.2% of Exponent shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Avalon GloboCare and Exponent, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Avalon GloboCare0000N/A
Exponent01102.50

Exponent has a consensus target price of $94.00, indicating a potential downside of 3.42%. Given Exponent's higher possible upside, analysts clearly believe Exponent is more favorable than Avalon GloboCare.

Summary

Exponent beats Avalon GloboCare on 8 of the 11 factors compared between the two stocks.

Avalon GloboCare (NASDAQ:AVCO) and FTI Consulting (NYSE:FCN) are both business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, profitability, institutional ownership, risk and valuation.

Volatility and Risk

Avalon GloboCare has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500. Comparatively, FTI Consulting has a beta of 0.41, indicating that its stock price is 59% less volatile than the S&P 500.

Valuation & Earnings

This table compares Avalon GloboCare and FTI Consulting's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avalon GloboCare$1.55 million53.74$-18,070,000.00N/AN/A
FTI Consulting$2.35 billion2.12$216.73 million$5.8025.13

FTI Consulting has higher revenue and earnings than Avalon GloboCare.

Profitability

This table compares Avalon GloboCare and FTI Consulting's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Avalon GloboCare-1,071.90%-314.81%-134.45%
FTI Consulting7.56%13.27%7.18%

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Avalon GloboCare and FTI Consulting, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Avalon GloboCare0000N/A
FTI Consulting00103.00

FTI Consulting has a consensus target price of $167.00, indicating a potential upside of 14.58%. Given FTI Consulting's higher possible upside, analysts clearly believe FTI Consulting is more favorable than Avalon GloboCare.

Insider and Institutional Ownership

3.2% of Avalon GloboCare shares are owned by institutional investors. Comparatively, 97.3% of FTI Consulting shares are owned by institutional investors. 73.4% of Avalon GloboCare shares are owned by insiders. Comparatively, 2.2% of FTI Consulting shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

FTI Consulting beats Avalon GloboCare on 8 of the 11 factors compared between the two stocks.

Avalon GloboCare (NASDAQ:AVCO) and ICF International (NASDAQ:ICFI) are both small-cap business services companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.

Analyst Recommendations

This is a breakdown of current recommendations for Avalon GloboCare and ICF International, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Avalon GloboCare0000N/A
ICF International00403.00

ICF International has a consensus target price of $102.00, indicating a potential upside of 13.37%. Given ICF International's higher possible upside, analysts plainly believe ICF International is more favorable than Avalon GloboCare.

Volatility and Risk

Avalon GloboCare has a beta of 0.57, indicating that its share price is 43% less volatile than the S&P 500. Comparatively, ICF International has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500.

Profitability

This table compares Avalon GloboCare and ICF International's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Avalon GloboCare-1,071.90%-314.81%-134.45%
ICF International4.19%10.77%4.85%

Insider & Institutional Ownership

3.2% of Avalon GloboCare shares are owned by institutional investors. Comparatively, 88.3% of ICF International shares are owned by institutional investors. 73.4% of Avalon GloboCare shares are owned by insiders. Comparatively, 4.3% of ICF International shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Valuation and Earnings

This table compares Avalon GloboCare and ICF International's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avalon GloboCare$1.55 million53.74$-18,070,000.00N/AN/A
ICF International$1.48 billion1.15$68.94 million$4.1521.68

ICF International has higher revenue and earnings than Avalon GloboCare.

Summary

ICF International beats Avalon GloboCare on 9 of the 11 factors compared between the two stocks.


Avalon GloboCare Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
CGI logo
GIB
CGI
1.9$85.15+1.2%$21.61 billion$9.04 billion27.20Upcoming Earnings
Analyst Upgrade
Booz Allen Hamilton logo
BAH
Booz Allen Hamilton
2.1$83.39+1.7%$11.48 billion$7.46 billion22.72
Genpact logo
G
Genpact
1.9$44.72+0.4%$8.37 billion$3.52 billion27.78Insider Selling
Exponent logo
EXPO
Exponent
1.6$97.33+1.7%$5.04 billion$417.20 million64.89
FTI Consulting logo
FCN
FTI Consulting
1.6$145.75+0.3%$4.99 billion$2.35 billion29.93
ICF International logo
ICFI
ICF International
2.1$89.97+1.6%$1.70 billion$1.48 billion27.94
Apollo Medical logo
AMEH
Apollo Medical
0.8$26.44+1.3%$1.44 billion$560.62 million28.43
The RMR Group logo
RMR
The RMR Group
1.4$40.02+0.1%$1.26 billion$589.51 million22.74Dividend Announcement
Analyst Report
Huron Consulting Group logo
HURN
Huron Consulting Group
1.7$54.22+0.8%$1.25 billion$965.47 million-271.09News Coverage
The Hackett Group logo
HCKT
The Hackett Group
2.2$17.01+0.1%$514.31 million$282.47 million85.05Decrease in Short Interest
Atlas Technical Consultants logo
ATCX
Atlas Technical Consultants
1.3$8.98+8.0%$316.81 millionN/A-9.87
BlackRock Capital Investment logo
BKCC
BlackRock Capital Investment
1.0$3.66+0.3%$272.55 million$78.12 million-2.19
Information Services Group logo
III
Information Services Group
1.3$4.31+0.2%$208.61 million$265.76 million71.85
ATIF
ATIF
0.5$1.06+1.9%$49.84 million$690,000.000.00
Lightbridge logo
LTBR
Lightbridge
0.6$4.99+2.0%$32.81 millionN/A-1.81
Wilhelmina International logo
WHLM
Wilhelmina International
0.8$6.11+15.1%$31.51 million$75.50 million-3.01Insider Selling
Decrease in Short Interest
Gap Up
HUSN
Hudson Capital
0.2$2.23+3.1%$14.29 million$1.37 million0.00Increase in Short Interest
This page was last updated on 4/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.